Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares gapped down prior to trading on Wednesday . The stock had previously closed at $16.71, but opened at $16.09. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.09, with a volume of 4,499 shares trading hands.

Analyst Upgrades and Downgrades

TLX has been the subject of several research reports. William Blair reiterated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th. UBS Group increased their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 3.6 %

The stock’s fifty day simple moving average is $17.92.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.